Advertisement

Digestive Diseases and Sciences

, Volume 56, Issue 10, pp 2972–2977 | Cite as

Disease-Specific Knowledge, Coping, and Adherence in Patients with Inflammatory Bowel Disease

  • Anilga MoradkhaniEmail author
  • Lauren Kerwin
  • Sharon Dudley-Brown
  • James H. Tabibian
Original Article

Abstract

Background

Little is known about the effects of disease-related education and knowledge in individuals with inflammatory bowel disease (IBD). The limited available research on this topic suggests there may be potential benefits to disease-related patient education. We hypothesized that individuals with greater IBD knowledge would have more coping strategies and higher medication adherence.

Methods

A total of 111 adults with IBD residing in the United States were recruited online by convenience sampling from IBD support group forums. IBD knowledge, coping, and medication adherence were assessed using standardized questionnaires. Data on seventeen clinico-demographic variables were also collected. A Pearson correlation was conducted to examine the relationship between IBD knowledge and use of coping strategies and also between IBD knowledge and medication adherence. Multivariate regression and one-way ANOVA tests were used to assess the continuous and categorical clinico-demographic variables, respectively, for potential confounding.

Results

A significant positive association was found between greater IBD knowledge and active coping scores (r = 0.189, P = 0.024), instrumental support scores (r = 0.160, P = 0.047), planning scores (r = 0.159, P = 0.048), and emotional support scores (r = 0.159, P = 0.048). A relationship between knowledge and adherence score was not found. Significant relationships were found between four clinico-demographic variables and coping.

Conclusion

Greater IBD knowledge appears to be associated with the use of more adaptive coping strategies in patients with IBD, suggesting that providing disease-related patient education may enhance coping in this population. Future studies should explore the utility of formal disease-related patient education in improving these and other outcomes.

Keywords

Inflammatory bowel diseases Crohn disease Colitis Medication adherence Knowledge 

Notes

Acknowledgments

We thank Linda Beckman, Ph.D., for her mentorship, Jayne Eaden, M.D., for her permission to use the CCKNOW, and Donald Morisky, M.D., for his permission to use the MMAS-4.

Conflicts of interest

None.

References

  1. 1.
    Dudley-Brown S. Prevention of psychological distress in persons with inflammatory bowel disease. Issues Ment Health Nurs. 2002;23:403–422.PubMedCrossRefGoogle Scholar
  2. 2.
    Crohn’s and Colitis Foundation of America. Retrieved from: http://www.ccfa.org/; 2009. Cited October 13, 2009.
  3. 3.
    Drossman DA, Patrick DL, Mitchell CM, Zagami EA, Appelbaum MI. Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns. Dig Dis Sci. 1989;34:1379–1386.PubMedCrossRefGoogle Scholar
  4. 4.
    Drossman DA, Leserman J, Li ZM, Mitchell CM, Zagami EA, Patrick DL. The rating form of IBD patient concerns: A new measure of health status. Dig Dis Sci. 1991;36:1746–1755.PubMedCrossRefGoogle Scholar
  5. 5.
    Dudley-Brown S, Nag A, Cullinan C, Ayers M, Hass S, Panjabi S. Health-related quality-of-life evaluation of Crohn disease patients after receiving natalizumab therapy. Gastroenterol Nurs. 2009;32:327–339.PubMedCrossRefGoogle Scholar
  6. 6.
    Larsson K, Lööf L, Rönnblom A, Nordin K. Quality of life for patients with exacerbation in inflammatory bowel disease and how they cope with disease activity. J Psychosom Res. 2008;64:139–148.PubMedCrossRefGoogle Scholar
  7. 7.
    Lix LM, Graff LA, Walker JR, et al. Longitudinal study of quality of life and psychological functioning for active, fluctuating, and inactive disease patterns in inflammatory bowel disease. Inflamm Bowel Dis. 2008;14:1575–1584.PubMedCrossRefGoogle Scholar
  8. 8.
    Hawthorne AB, Rubin G, Ghosh S. Review article: medication non-adherence in ulcerative colitis-strategies to improve adherence with mesalazine and other maintenance therapies. Aliment Pharmacol Ther. 2008;27:1157–1166.PubMedCrossRefGoogle Scholar
  9. 9.
    Sood A, Midha V, Sood N, Kaushal V. Self-reported disease awareness—A questionnaire survey of ulcerative colitis patients. Indian J Gastroenterol. 2001;20:6–8.PubMedGoogle Scholar
  10. 10.
    Cervený P, Bortlík M, Kubena A, Vlcek J, Lakatos PL, Lukás M. Nonadherence in inflammatory bowel disease: Results of factor analysis. Inflamm Bowel Dis. 2007;13:1244–1249.PubMedCrossRefGoogle Scholar
  11. 11.
    Jones SC, Gallacher B, Lobo AJ, Axon AT. A patient knowledge questionnaire in inflammatory bowel disease. J Clin Gastroenterol. 1993;17:21–24.PubMedCrossRefGoogle Scholar
  12. 12.
    Sewitch MJ, Abrahamowicz M, Barkun A, Bitton A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol. 2003;98:1535–1544.PubMedCrossRefGoogle Scholar
  13. 13.
    Mazzuca SA. Does patient education in chronic disease have therapeutic value? J Chronic Dis. 1982;35:521–529.PubMedCrossRefGoogle Scholar
  14. 14.
    Quan H, Present JW, Sutherland LR. Evaluation of educational programs in inflammatory bowel disease. Inflamm Bowel Dis. 2003;9:356–362.PubMedCrossRefGoogle Scholar
  15. 15.
    Scholmerich J, Sedlak P, Hoppe-Seyler P, Gerok W. The information needs and fears of patients with inflammatory bowel disease. Hepatogastroenterology. 1987;34:182–185.PubMedGoogle Scholar
  16. 16.
    Casati J, Toner BB, De Rooy EC, Drossman DA, Maunder RG. Concerns of patients with inflammatory bowel disease: A review of emerging themes. Dig Dis Sci. 2000;45:26–31.PubMedCrossRefGoogle Scholar
  17. 17.
    Cima RR, Anderson KJ, Larson DW, et al. Internet use by patients in an inflammatory bowel disease specialty clinic. Inflamm Bowel Dis. 2007;13:1266–1270.PubMedCrossRefGoogle Scholar
  18. 18.
    Oxelmark L, Magnusson A, Löfberg R, Hillerås P. Group-based intervention program in inflammatory bowel disease patients: Effects on quality of life. Inflamm Bowel Dis. 2007;13:182–190.PubMedCrossRefGoogle Scholar
  19. 19.
    Kennedy A, Robinson A, Hann M, Thompson D, Wilkin D. A cluster-randomised controlled trial of a patient-centered guidebook for patients with ulcerative colitis: Effect on knowledge, anxiety and quality of life. Health Soc Care Commun. 2003;11:64–72.CrossRefGoogle Scholar
  20. 20.
    Dorrian A, Dempster M, Adair P. Adjustment to inflammatory bowel disease: The relative influence of illness perceptions and coping. Inflamm Bowel Dis. 2009;15:47–55.PubMedCrossRefGoogle Scholar
  21. 21.
    Moser G, Tillinger W, Sachs G, et al. Disease-related worries and concerns: A study on out-patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1995;7:853–858.PubMedGoogle Scholar
  22. 22.
    Probert CS, Mayberry JF. Inflammatory bowel disease: Patients’ expectations in the 1990s. J R Soc Med. 1991;84:131–132.PubMedGoogle Scholar
  23. 23.
    Waters BM, Jensen L, Fedorak RN. Effects of formal education for patients with inflammatory bowel disease: A randomized controlled trial. Can J Gastroenterol. 2005;19:235–244.PubMedGoogle Scholar
  24. 24.
    Eaden JA, Abrams K, Mayberry JF. The Crohn’s and Colitis knowledge score: A test for measuring patient knowledge in inflammatory bowel disease. Am J Gastroenterol. 1999;94:3560–3566.PubMedCrossRefGoogle Scholar
  25. 25.
    Carver CS. You want to measure coping but your protocol’s too long: Consider the brief COPE. Int J Behav Med. 1997;4:92–100.PubMedCrossRefGoogle Scholar
  26. 26.
    Carver CS, Scheier MF, Weintraub JK. Assessing coping strategies: A theoretically based approach. J Pers Soc Psychol. 1989;56:267–283.PubMedCrossRefGoogle Scholar
  27. 27.
    Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence and long-term predictive validity of blood pressure control. Med Care. 1986;24:67–74.PubMedCrossRefGoogle Scholar
  28. 28.
    Martin A, Leone L, Castagliuolo I, Di Mario F, Naccarato R. What do patients want to know about their inflammatory bowel disease? Ital J Gastroenterol. 1992;24:477–480.PubMedGoogle Scholar
  29. 29.
    Finlay DG, Basu D, Sellin JH. Effect of race and ethnicity on perceptions of inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:503–507.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Anilga Moradkhani
    • 1
    Email author
  • Lauren Kerwin
    • 1
  • Sharon Dudley-Brown
    • 2
  • James H. Tabibian
    • 3
  1. 1.California School of Professional PsychologyAlliant International UniversityAlhambraUSA
  2. 2.Schools of Medicine & NursingJohns Hopkins UniversityBaltimoreUSA
  3. 3.Division of Gastroenterology and HepatologyMayo ClinicRochesterUSA

Personalised recommendations